electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10 Jan in Las Vegas, USA. The technology enables chronic respiratory disease (CRD) patients to detect and monitor digital biomarkers of lung function at home, while providing clinicians with real-time data to customise treatment plans and help improve patient outcomes.